In oral squamous cell carcinoma, the upregulation of FOXM1 has been shown to correlate with tumor growth [28], and FOXP3-mediated immune modulation appeared to potentiate the anti-tumor effectiveness of regulatory T cell-based immunotherapy [29]. This evidence concerns the gene FOXP3 and neoplasm.